Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Beschreibung
This new edition builds upon the foundational knowledge covered in the first edition, covering the epidemiology, pathogenesis, and clinical presentation of atopic dermatitis in both pediatric and adult patients. It provides an overview of the mechanism and presentation of atopic dermatitis and focuses on the management methods experienced dermatologists have used to successfully manage atopic dermatitis. The book includes new chapters describing the special considerations for atopic dermatitis in skin of color patients, dedicated chapters on topical and oral prescription management reflected the latest FDA-approved treatments, and also a chapter covering the updated guidelines from the American Academy of Dermatology. A final chapter includes updates on the future of atopic dermatitis treatment.

This book provides physicians with insights into the management of atopic dermatitis, such as alternative treatments for pruritus, psychosocial impact on patients and families,assessing patient compliance, and patient resources.
This new edition builds upon the foundational knowledge covered in the first edition, covering the epidemiology, pathogenesis, and clinical presentation of atopic dermatitis in both pediatric and adult patients. It provides an overview of the mechanism and presentation of atopic dermatitis and focuses on the management methods experienced dermatologists have used to successfully manage atopic dermatitis. The book includes new chapters describing the special considerations for atopic dermatitis in skin of color patients, dedicated chapters on topical and oral prescription management reflected the latest FDA-approved treatments, and also a chapter covering the updated guidelines from the American Academy of Dermatology. A final chapter includes updates on the future of atopic dermatitis treatment.

This book provides physicians with insights into the management of atopic dermatitis, such as alternative treatments for pruritus, psychosocial impact on patients and families,assessing patient compliance, and patient resources.
Über den Autor

Lindsay C. Strowd is an Associate Professor and Interim Chair of Dermatology at the Wake Forest University School of Medicine.

Steven R. Feldman is a Professor of Dermatology and Public Health Sciences at the Wake Forest University School of Medicine.

Katie K. Lovell is a research fellow in the Department of Dermatology at the Wake Forest University School of Medicine and M.D. Candidate at East Carolina University Brody School of Medicine.

Inhaltsverzeichnis
Introduction.- Atopic Dermatitis: Disease Background and Risk Factors.- Atopic Dermatitis: Pathophysiology.- Clinical Presentation of Atopic Dermatitis.- Special Considerations for Atopic Dermatitis in Skin of Color Patients.- Atopic Dermatitis Disease Complications.- The Psychosocial Impact of Atopic Dermatitis.- Stressors in Atopic Dermatitis.- The Economics Burden of Atopic Dermatitis.- Defining and Measuring the Scope of Atopic Dermatitis.- Topical Prescription Management (including new topical JAK).- Oral Prescription Management (including new oral JAKs).-Introduction.- Atopic Dermatitis: Disease Background and Risk Factors.- Atopic Dermatitis: Pathophysiology.- Clinical Presentation of Atopic Dermatitis.- Special Considerations for Atopic Dermatitis in Skin of Color Patients.- Atopic Dermatitis Disease Complications.- The Psychosocial Impact of Atopic Dermatitis.- Stressors in Atopic Dermatitis.- The Economics Burden of Atopic Dermatitis.- Defining and Measuring the Scope of Atopic Dermatitis.- Topical Prescription Management (including new topical JAK).- Oral Prescription Management (including new oral JAKs).- Systemic Biologic Management (dupilumab and tralokinumab).- Non-Prescription Treatment Options.- Adherence in Atopic Dermatitis.- Atopic Dermatitis: Managing the Itch.- Atopic Dermatitis Disease Education.- Guidelines from American Academy of Dermatology.- The Future of Atopic Dermatitis Treatment (to be updated-some drugs discussed in this chapter are now FDA approved).
Details
Erscheinungsjahr: 2025
Fachbereich: Andere Fachgebiete
Genre: Mathematik, Medizin, Naturwissenschaften, Technik
Rubrik: Wissenschaften
Medium: Taschenbuch
Reihe: Advances in Experimental Medicine and Biology
Inhalt: x
248 S.
2 s/w Illustr.
7 farbige Illustr.
248 p. 9 illus.
7 illus. in color.
ISBN-13: 9783031545153
ISBN-10: 303154515X
Sprache: Englisch
Einband: Kartoniert / Broschiert
Redaktion: Feldman, Steven R.
Strowd, Lindsay C.
Lovell, Katie K.
Herausgeber: Steven R Feldman/Lindsay C Strowd/Katie K Lovell
Auflage: Second Edition 2024
Hersteller: Springer
Springer International Publishing AG
Advances in Experimental Medicine and Biology
Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, D-69121 Heidelberg, juergen.hartmann@springer.com
Maße: 235 x 155 x 15 mm
Von/Mit: Steven R. Feldman (u. a.)
Erscheinungsdatum: 10.05.2025
Gewicht: 0,4 kg
Artikel-ID: 133196668